Form 8-K - Current report:
SEC Accession No. 0001404644-24-000091
Filing Date
2024-11-12
Accepted
2024-11-12 06:05:25
Documents
62
Period of Report
2024-11-11
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ngne-20241111.htm   iXBRL 8-K 28566
2 EX-99.1 a202411_ngn-401interimclin.htm EX-99.1 28913
3 EX-99.2 a202411_ngn-401webcastsl.htm EX-99.2 59589
7 a202411_ngn-401webcastsl001.jpg GRAPHIC 105290
8 a202411_ngn-401webcastsl002.jpg GRAPHIC 295445
9 a202411_ngn-401webcastsl003.jpg GRAPHIC 62415
10 a202411_ngn-401webcastsl004.jpg GRAPHIC 151580
11 a202411_ngn-401webcastsl005.jpg GRAPHIC 128770
12 a202411_ngn-401webcastsl006.jpg GRAPHIC 126577
13 a202411_ngn-401webcastsl007.jpg GRAPHIC 37010
14 a202411_ngn-401webcastsl008.jpg GRAPHIC 83205
15 a202411_ngn-401webcastsl009.jpg GRAPHIC 134925
16 a202411_ngn-401webcastsl010.jpg GRAPHIC 38722
17 a202411_ngn-401webcastsl011.jpg GRAPHIC 104270
18 a202411_ngn-401webcastsl012.jpg GRAPHIC 110318
19 a202411_ngn-401webcastsl013.jpg GRAPHIC 129905
20 a202411_ngn-401webcastsl014.jpg GRAPHIC 134619
21 a202411_ngn-401webcastsl015.jpg GRAPHIC 98159
22 a202411_ngn-401webcastsl016.jpg GRAPHIC 99091
23 a202411_ngn-401webcastsl017.jpg GRAPHIC 95766
24 a202411_ngn-401webcastsl018.jpg GRAPHIC 102198
25 a202411_ngn-401webcastsl019.jpg GRAPHIC 151913
26 a202411_ngn-401webcastsl020.jpg GRAPHIC 113322
27 a202411_ngn-401webcastsl021.jpg GRAPHIC 129640
28 a202411_ngn-401webcastsl022.jpg GRAPHIC 126257
29 a202411_ngn-401webcastsl023.jpg GRAPHIC 99369
30 a202411_ngn-401webcastsl024.jpg GRAPHIC 102374
31 a202411_ngn-401webcastsl025.jpg GRAPHIC 114796
32 a202411_ngn-401webcastsl026.jpg GRAPHIC 79826
33 a202411_ngn-401webcastsl027.jpg GRAPHIC 130912
34 a202411_ngn-401webcastsl028.jpg GRAPHIC 30071
35 a202411_ngn-401webcastsl029.jpg GRAPHIC 124714
36 a202411_ngn-401webcastsl030.jpg GRAPHIC 113423
37 a202411_ngn-401webcastsl031.jpg GRAPHIC 118430
38 a202411_ngn-401webcastsl032.jpg GRAPHIC 106410
39 a202411_ngn-401webcastsl033.jpg GRAPHIC 96228
40 a202411_ngn-401webcastsl034.jpg GRAPHIC 69955
41 a202411_ngn-401webcastsl035.jpg GRAPHIC 96220
42 a202411_ngn-401webcastsl036.jpg GRAPHIC 69407
43 a202411_ngn-401webcastsl037.jpg GRAPHIC 129896
44 a202411_ngn-401webcastsl038.jpg GRAPHIC 26563
45 a202411_ngn-401webcastsl039.jpg GRAPHIC 69529
46 a202411_ngn-401webcastsl040.jpg GRAPHIC 25986
47 a202411_ngn-401webcastsl041.jpg GRAPHIC 30634
48 a202411_ngn-401webcastsl042.jpg GRAPHIC 91664
49 a202411_ngn-401webcastsl043.jpg GRAPHIC 138357
50 a202411_ngn-401webcastsl044.jpg GRAPHIC 129941
51 a202411_ngn-401webcastsl045.jpg GRAPHIC 119988
52 a202411_ngn-401webcastsl046.jpg GRAPHIC 88133
53 image_0.jpg GRAPHIC 3474
  Complete submission text file 0001404644-24-000091.txt   6842495

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ngne-20241111.xsd EX-101.SCH 1788
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ngne-20241111_lab.xml EX-101.LAB 22548
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ngne-20241111_pre.xml EX-101.PRE 13050
64 EXTRACTED XBRL INSTANCE DOCUMENT ngne-20241111_htm.xml XML 2802
Mailing Address 535 W 24TH STREET 5TH FLOOR NEW YORK NY 10011
Business Address 535 W 24TH STREET 5TH FLOOR NEW YORK NY 10011 (877) 237-5020
Neurogene Inc. (Filer) CIK: 0001404644 (see all company filings)

EIN.: 980542593 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36327 | Film No.: 241442802
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)